Medical Condition News

RSS

Sanofi-aventis, Oxford University to conduct multi-phase oncology research in India

Sanofi-aventis US and Oxford University have entered into an agreement to conduct multi-phase oncology clinical and epidemiological research with INDOX, India's leading academic oncology network.

20 Dec 2010

4SC AG's Phase IIb study evaluates efficacy of vidofludimus in RA patients

4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, today reported that it has completed enrolment of its COMPONENT Phase IIb study with vidofludimus, an oral inhibitor of IL-17 release, in rheumatoid arthritis (RA) patients. Data from the trial are expected to be announced in Q2 2011.

20 Dec 2010

EpiTherapeutics, Abbott to develop new anti-cancer drugs

EpiTherapeutics and Abbott today announced a collaboration agreement to develop new anti-cancer drugs by making small-molecule inhibitors against selected epigenetic oncology targets.

20 Dec 2010

Avila, sanofi-aventis enter global alliance to discover targeted covalent drugs for treatment of cancers

Avila Therapeutics, Inc. announced today that it has signed a worldwide strategic alliance with sanofi-aventis to discover targeted covalent drugs for the treatment of cancers. Under the alliance agreement sanofi-aventis obtains a worldwide exclusive license to develop and commercialize the compounds resulting from the discovery collaboration.

20 Dec 2010

$FDA approves Medtronic's Arctic Front Cardiac CryoAblation Catheter system for drug refractory PAF$

FDA approves Medtronic's Arctic Front Cardiac CryoAblation Catheter system for drug refractory PAF

Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its Arctic Front® Cardiac CryoAblation Catheter system, the first and only Cryoballoon in the United States indicated for the treatment of drug refractory paroxysmal atrial fibrillation (PAF). The Cryoballoon treatment involves a minimally-invasive procedure that efficiently creates circumferential lesions around the pulmonary vein, which is the source of erratic electrical signals that cause the irregular heartbeat.

20 Dec 2010

State Roundup: UMass bone marrow registry practices probed; Insurance woes hit many Calif. middle income families

Bone marrow registries are usually noble efforts to find donors with the right genetic match to save the life of a terminally ill person, but one such program in New England is under investigation by attorneys general in two states (Greenberg, 12/17).

20 Dec 2010

RXi's dermal anti-scarring candidate selected to advance into development

RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced the selection of its first RNAi therapeutic product candidate to advance into development.

20 Dec 2010

Researchers examine socio-economic consequences of hypersomnia

Danish sleep researchers at the University of Copenhagen and the Danish Institute for Health Services Research have examined the socio-economic consequences of the sleep disorder hypersomnia in one of the largest studies of its kind.

20 Dec 2010

Significant gap exists in medical services for ER patients

Almost three quarters of hospital emergency department administrators nationwide report that lack of medical specialists at their facilities poses a risk to ER patients – in some cases a very significant risk.

20 Dec 2010

Study finds second skin barrier structure may play a role in eczema development

Like a fence or barricade intended to stop unwanted intruders, the skin serves as a barrier protecting the body from the hundreds of allergens, irritants, pollutants and microbes people come in contact with every day.

20 Dec 2010

Nanosphere's Verisens cTnI assay measures low levels of troponin I in patients with heart failure

A clinical study released online by the European Journal of Heart Failure, a publication of the European Society of Cardiology, demonstrates the value of using Nanosphere's Verisens cTnI assay to detect very low levels of troponin I in hospitalized patients with heart failure.

20 Dec 2010

SAGE publishes first comprehensive textbook on psychology

Psychology for medicine, published today by SAGE, is the first comprehensive textbook on psychology for medical students that is relevant to all of their undergraduate studies.

20 Dec 2010

GSI scientists irradiate human tumor tissue to enhance ion beam therapy

Cancer treatment with ion beams developed at GSI is characterized by an excellent cure rate and only minor side effects. The therapy has been routinely in use for a little over one year.

20 Dec 2010

Scientists suggest targeting ion channels could offer effective pain relief

University at Buffalo neuroscience researchers conducting basic research on ion channels have demonstrated a process that could have a profound therapeutic impact on pain.

20 Dec 2010

Arthrosurface conducts first knee procedure based on HemiCAP platform technology

Arthrosurface, Inc., the developer of less-invasive joint resurfacing systems, announced that it has performed its first biological knee procedure based on the company's proven HemiCAP® platform technology.

19 Dec 2010

CF patients with normal to mildly impaired lung function may benefit from new investigational drug

Cystic fibrosis patients with normal to mildly impaired lung function may benefit from a new investigational drug designed to help prevent formation of the sticky mucus that is a hallmark of the disease, according to researchers involved in a phase 3 clinical trial of the drug.

19 Dec 2010

Completely fearless woman stirs scientific interest

It has been known since the 1930s that when a certain part of monkeys’ brains were removed, the animals became fearless. Now similar effects are being seen in humans according to a study in the journal Current Biology. Justin Feinstein, the study’s lead author and a clinical neuropsychologist at the University of Iowa said, “There’s not very many humans with this sort of brain damage… Luckily for us, we had access to a patient, SM, and we studied her different fear behaviours and we read her personal diaries.”

19 Dec 2010

UCLA report: Low-income Californians with asthma experience more frequent symptoms

Almost 5 million Californians have been diagnosed with asthma, and those living in poverty suffer more severe consequences from the condition than those in higher income brackets, according to a new report from the UCLA Center for Health Policy Research.

17 Dec 2010

InspireMD presents long-term data of MGuard stent technology at the ICI

InspireMD, developer of the novel MGuard(TM), a combination of a coronary stent merged with an embolic protection specifically designed for Acute MI (AMI) patients, received significant exposure at the ICI, Innovations in Interventional Cardiology, meeting this week in Tel-Aviv. InspireMD presented long-term data, including two years of clinical follow-up, to support the Company's MGuard stent technology.

17 Dec 2010

Taiho receives CHMP positive opinion on Teysuno in combination with cisplatin for advanced gastric cancer

Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka Holdings Co., Ltd., announced today that the Committee for Medicinal Products for Human Use (CHMP), a division of the European Medicines Agency (EMA), has issued an opinion recommending approval of Teysuno™ (S-1), a novel oral anti-cancer agent, intended for the treatment of advanced gastric cancer in adults when given in combination with cisplatin.

17 Dec 2010

Medical Condition News

Sanofi-aventis, Oxford University to conduct multi-phase oncology research in India

4SC AG's Phase IIb study evaluates efficacy of vidofludimus in RA patients

EpiTherapeutics, Abbott to develop new anti-cancer drugs

Avila, sanofi-aventis enter global alliance to discover targeted covalent drugs for treatment of cancers

FDA approves Medtronic's Arctic Front Cardiac CryoAblation Catheter system for drug refractory PAF

State Roundup: UMass bone marrow registry practices probed; Insurance woes hit many Calif. middle income families

RXi's dermal anti-scarring candidate selected to advance into development

Researchers examine socio-economic consequences of hypersomnia

Significant gap exists in medical services for ER patients

Study finds second skin barrier structure may play a role in eczema development

Nanosphere's Verisens cTnI assay measures low levels of troponin I in patients with heart failure

SAGE publishes first comprehensive textbook on psychology

GSI scientists irradiate human tumor tissue to enhance ion beam therapy

Scientists suggest targeting ion channels could offer effective pain relief

Arthrosurface conducts first knee procedure based on HemiCAP platform technology

CF patients with normal to mildly impaired lung function may benefit from new investigational drug

Completely fearless woman stirs scientific interest

UCLA report: Low-income Californians with asthma experience more frequent symptoms

InspireMD presents long-term data of MGuard stent technology at the ICI

Taiho receives CHMP positive opinion on Teysuno in combination with cisplatin for advanced gastric cancer

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News